This activity provides education to assist clinicians in improving care of patients with PNH through a greater understanding of pathophysiologic mechanisms of PNH, the limitations of current therapies and their impact on patients’ quality of life and outcomes, the latest data on emerging treatment options, and how these treatments may impact clinical care.
This activity is intended for medical professionals.
This activity is supported by an independent medical educational grant from Novartis.
18 июн 2024
